Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 8/20 | 0.70 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.70 |
| ▸ | MAPT | P10636 | 8/20 | 0.48 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 5/20 | 0.48 |
| ▸ | MEN1 | O00255 | 4/20 | 0.48 |
| ▸ | HPGD | P15428 | 2/20 | 0.48 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.48 |
| ▸ | ALDH3A1 | P30838 | 1/20 | 0.46 |
| ▸ | ALDH1A3 | P47895 | 1/20 | 0.46 |
| ▸ | GAA | P10253 | 1/20 | 0.44 |
| ▸ | BACE1 | P56817 | 4/20 | 0.43 |
| ▸ | LMNA | P02545 | 2/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | USP2 | O75604 | 1/20 | 0.41 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.41 |
| ▸ | MAOB | P27338 | 1/20 | 0.41 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.41 |
| ▸ | ATM | Q13315 | 1/20 | 0.41 |
| ▸ | CRHBP | P24387 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8415573 | 0.88 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1MAPTKDM4EKMT2A | |
| SCHEMBL8415313 | 0.87 | ALDH1A1 (0.54) | ALDH1A1L3MBTL1MAPTKDM4EKMT2A | |
| SCHEMBL7598406 | 0.86 | ALDH1A1 (0.56) | ALDH1A1L3MBTL1MAPTKDM4EKMT2A | |
| SCHEMBL7863602 | 0.84 | ALDH1A1 (0.65) | ALDH1A1L3MBTL1MAPTKDM4EKMT2A | |
| SCHEMBL28338105 | 0.84 | ALDH1A1 (0.65) | ALDH1A1L3MBTL1MAPTKDM4EKMT2A | |
| SCHEMBL10425633 | 0.83 | ALDH1A1 (0.49) | ALDH1A1L3MBTL1MAPTKDM4EKMT2A | |
| SCHEMBL22587845 | 0.83 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1MAPTKDM4EKMT2A | |
| SCHEMBL2950989 | 0.83 | ALDH1A1 (1.00) | ALDH1A1L3MBTL1MAPTKDM4EKMT2A | |
| SCHEMBL1646997 | 0.82 | ALDH1A1 (0.62) | ALDH1A1L3MBTL1MAPTKDM4EKMT2A | |
| SCHEMBL7521809 | 0.82 | ALDH1A1 (0.48) | ALDH1A1L3MBTL1MAPTKDM4EKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4419206-B1 | COMPOUNDS FOR THE TREATMENT OF MALARIA | FUNDACIO INST DE BIOENGINYERIA DE CATALUNYA (ES) | 2025-09-17 | — | — | EP | disclosed |
| US-20240415825-A1 | COMPOUNDS FOR THE TREATMENT OF MALARIA | Fundación Privada Instituto De Salud Global Barcelona (ES) | 2024-12-19 | — | — | US | disclosed |
| EP-4419206-A1 | COMPOUNDS FOR THE TREATMENT OF MALARIA | Fundacio Institut de Bioenginyeria de Catalunya (ES) | 2024-08-28 | — | — | EP | disclosed |
| WO-2023067170-A1 | COMPOUNDS FOR THE TREATMENT OF MALARIA | FUNDACIÓ INSTITUT DE BIOENGINYERIA DE CATALUNYA (ES) | 2023-04-27 | — | — | WO | disclosed |
| WO-2013068592-A1 | INHIBITORS OF CYSTATHIONINE BETA SYNTHASE TO REDUCE THE NEUROTOXIC OVERPRODUCTION OF ENDOGENOUS HYDROGEN SULFIDE | FONDATION JEROME LEJEUNE (FR) | 2013-05-16 | — | — | WO | disclosed |
| WO-2013068592-A1 | INHIBITORS OF CYSTATHIONINE BETA SYNTHASE TO REDUCE THE NEUROTOXIC OVERPRODUCTION OF ENDOGENOUS HYDROGEN SULFIDE | FONDATION JEROME LEJEUNE (FR) | 2013-05-16 | — | — | WO | disclosed |
| EP-0326133-B1 | Organic nonlinear optical material and nonlinear optical device | NIPPON TELEGRAPH & TELEPHONE (JP) | 1994-12-07 | — | — | EP | disclosed |
| US-4999139-A | Aminonitrostyrene Compound; Including a Polarizer, an Optical Resonator an a Reflector | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1991-03-12 | — | — | US | disclosed |
| US-4997595-A | Organic nonlinear optical material and nonlinear optical device | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1991-03-05 | — | — | US | disclosed |
| EP-0326133-A2 | Organic nonlinear optical material and nonlinear optical device | NIPPON TELEGRAPH AND TELEPHONE CORPORATION (JP) | 1989-08-02 | — | — | EP | disclosed |
| EP-0016418-B1 | WATER-INSOLUBLE IMINO COUMARIN DYESTUFFS, PROCESS FOR THEIR PREPARATION AND THEIR USE | HOECHST AKTIENGESELLSCHAFT (DE) | 1983-02-16 | — | — | EP | disclosed |
| EP-0016418-A1 | Water-insoluble imino coumarin dyestuffs, process for their preparation and their use | HOECHST AKTIENGESELLSCHAFT (DE) | 1980-10-01 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20240415825-A1 | COMPOUNDS FOR THE TREATMENT OF MALARIA | ABAT, GLS2, CPS1 | ALDH1A1 2819/4885L3MBTL1 916/4885MAPT 24/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.